Characterization of Patients With Geographic Atrophy (GA) in the US
Characterization of Patients With Geographic Atrophy (GA) in the US
To quantify and describe patients with a Geographic Atrophy (GA) diagnosis in at least one eye, and the progression to neovascular Age-Related Macular Degeneration (including how many receive Anti-VEGF), or to GA (in the fellow eye only).
Inclusion Criteria:
- All patients ≥50 years, with a GA diagnosis in at least one eye, included in the Vestrum database identified during the study period (January 2015 to April 2023).
Exclusion Criteria:
- Patients without the information of laterality will be excluded.